Arkolith/Insider Trading/NBIO/Form 4

Holden Lowell Thomas

CFO, DirectorNascent Biotech Inc. (NBIO) · full profile →Form 4 · filed Jul 2, 2024
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 30, 2024Other(J)96K$0.09$9K10.0M

Transaction Codes

J
Other acquisition / disposition

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001477932-24-004031) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML